Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  3SBio Inc. (ADR)    

3SBIO INC. (ADR)
Mes dernières consult.
Most popular
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in research, development, manufacturing and marketing of biopharmaceutical products

3SBio, Inc. operates as in investment holding company which engages in the development, production, marketing, and sale of biopharmaceutical products.

It is used in the field of medicine particularly in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.

The company was founded by Jing Lou and Dan Lou in 1993 and is headquartered in Shenyang, China.
Managers
NameAgeSinceTitle
Jing Lou MD, PhD541993Chairman, President & Chief Executive Officer
Wei hong Xiao-2016Chief Operating Officer
Bo Tan, MBA442009Chief Financial Officer & Executive Director
Zhenping Zhu MD, PhD-2017Chief Scientific Officer, President-R&D
Dong Mei Su, PhD462012Executive Director
Bin Huang, MBA561993Executive Director & Vice President
Dong Liu, MBA442014Non-Executive Director
Tian Ruo Pu, MBA472014Independent Non-Executive Director
David R. Parkinson MD, PhD652014Independent Non-Executive Director
Jun Ma, PhD542014Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 2,532,313,570 1,091,142,120 43.1% 0 0.0% 43.1%
Shareholders
NameEquities%
CITIC Private Equity Funds Management Co., Ltd. 621,512,360 24.5%
Jing Lou, MD, PhD 599,367,030 23.7%
Bo Tan, MBA 116,849,920 4.61%
Dan Lou 62,001,010 2.45%
OppenheimerFunds, Inc. 43,458,000 1.72%
The Vanguard Group, Inc. 32,849,500 1.30%
Bin Huang, MBA 32,197,350 1.27%
Dong Mei Su, PhD 25,585,630 1.01%
BlackRock Fund Advisors 22,729,000 0.90%
T. Rowe Price International Ltd. 18,447,000 0.73%
Sector Biopharmaceuticals
1st jan.Capitalization (M$)
3SBIO INC. (ADR)3 103
BIOGEN8.94%60 012
CSL LIMITED26.27%45 698
ALEXION PHARMACEUTICALS7.72%29 594
GRIFOLS SA22.33%17 146
BIOMARIN PHARMACEUTICAL7.77%15 578
CHONGQING ZHIFEI BIOLOGICAL PRDCT CO LTD--.--%4 486
3SBIO INC25.53%3 103
ABCAM PLC31.29%2 675
JIANGXI BOYA BIO-PHARMACEUTICAL CO LTD--.--%2 049
HUGEL INC--.--%1 810
BIOTEST AG79.03%1 180
PHARMA MAR SA43.17%1 007
PROMETIC LIFE SCIENCES INC.-29.82%912
ANIKA THERAPEUTICS INC-2.14%702
SYROS PHARMACEUTICALS INC69.08%506
CHEMOCENTRYX INC38.51%484
SYNDAX PHARMACEUTICALS INC93.86%304
STRONGBRIDGE BIOPHARMA PLC181.25%239
KAMADA LTD.-5.93%203
CO DON AG237.73%189
Connections : 3SBio Inc. (ADR)
Shanghai Aoxi Technology Information Consulting Co., Ltd.
Collected Mind Ltd.
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
Ample Harvest Investments Ltd.
Zhejiang Sunshine Pharmaceutical Co., Ltd.
Hong Kong Sansheng Ltd.
Shanghai Xingsheng Pharmaceutical Co., Ltd.
Liaoning Sunshine Science & Technology Development Co. Ltd.
Shenzhen Baishitong Technology Development Co., Ltd.
Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd.
UTStarcom, Inc.
CFA Institute
Taizhou Huan Sheng Investment Management Co., Ltd.
Shenyang Sunshine Pharmaceutical Co., Ltd.
Excel Partner Holdings Ltd.
Beingmate Group Co. Ltd.
Liaoning Sunshine Bio-Pharmaceutical Co. Ltd.
CITIC Industrial Investment Group Corp. Ltd.
The Multiple Myeloma Research Foundation, Inc.
Company contact information
3SBio, Inc.
Shenyang Economy & Tech Development
No. 3 A1, Road 10
Shenyang, Liaoning 110027

Phone : +86.24.25386000
Fax : +86.24.25811821
Web : www.3sbio.com
© 2017 People , Fundamentals and Ownership